It is proposed that the efficacy of CD8+ T cell anti-tumor immunity plays a critical role in eradicating disseminated tumor cells (DTCs) in mouse melanoma and breast cancer models, as evidenced by promoting metastasis with T cell depletion (114, 115). The gene discussed is CD8A; the disease is neoplasm.